Skip to main content

iwCLL 2023 Main banner

iwCLL X / Twitter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Alessio Bruscaggin, Dr

Institute of Oncology Research

NA

Poster(s):

1007 - XPO1 mutations identify early stage CLL characterized by shorter time to first treatment and enhanced BCR signaling